Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevenar in Infants With Sickle Cell Disease
NCT00368186Phase 4Terminated
- Sponsor
- Pfizer
- Start
- May 2001
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 7-valent conjugate vaccine in pneumococcal infection, sponsored by Pfizer. Started May 2001; status: terminated.
02
Drugs
pneumococcal 7-valent conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT00368186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00368186.